VERA SG&A Expense Growth

Vera Therapeutics Inc Class A · SG&A Expense Growth

VERA logo

VERA SG&A Expense Growth

Latest reported144.44%
VERA FY SG&A Growth (YoY) (0.00% → 144.44%)
High-resolution chart · PNG

VERA sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Vera Therapeutics Inc Class A SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
144.4436%
72.3546%
8.5669%
83.8396%
206.1392%
-11.7234%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.